- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06446076
Feedback Using behaviOral econOmic Theories on STEP countS in Cardiovascular Disease Patients (FOOTSTEPS)
May 12, 2025 updated by: Atsushi Mizuno, St. Luke's International Hospital, Japan
Feedback Using behaviOral econOmic Theories on STEP countS in Cardiovascular Disease Patients: A Randomized Controlled Trial
This is a prospective, randomized controlled trial.
The aim of the study is to verify the effectiveness of interventions using gamification with social incentives and social support to increase physical activity in patients with CVD through randomized controlled trials.
Study Overview
Status
Active, not recruiting
Intervention / Treatment
Detailed Description
The three aims of this randomized controlled trials;
- To demonstrate the effectiveness of loss framing in gamification for achieving increased physical activity in patients with CVD.
- To demonstrate the effectiveness of social support in gamification for achieving increased physical activity in patients with CVD.
- To evaluate the impact of the intervention using social incentives and social support through gamification on changes in participants; subjective assessment of physical activity levels, body mass index (BMI), and lipid panel in blood tests.
Secondary Objective:
- To assess whether the differences between study groups in achieving the goal of increased physical activity during the 6-week intervention period persist during the 6-week follow-up period.
- To investigate how the increase in physical activity through gamification in patients with CVD is influenced by patients; behavioral characteristics and environmental factors.
This trial will be a five-group, randomized controlled trial (RCT) with an intervention period of 6 weeks and a follow-up period of additional 6 weeks.
Study Type
Interventional
Enrollment (Estimated)
325
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Tokyo, Japan, 1048560
- St. Luke's International Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age 18 years or older
- History of old myocardial infarction or chronic heart failure
- Ability to read and provide informed consent to participate in this trial
- Owning a smartphone capable of installing this application
Exclusion Criteria:
- Having difficulty using smartphones (due to vision problems or IT literacy issues)
- Exercise therapy is contraindicated (in accordance with the 2021 revised guidelines on rehabilitation in cardiovascular diseases)
- Ability to read and provide informed consent to participate in this trial
- Owning a smartphone capable of installing this application
- Participating in other studies related to physical activity
- Being pregnant
- Any other medical conditions or reasons they are unable to participate in a physical activity study for 12 weeks
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control group
Participants in this group will not receive goal-setting or gamification interventions during the 6-week intervention period and the additional 6-week follow-up period.
As an "active control" during the 12-week trial period, participants will be able to check their daily step counts using an application with the same specifications.
|
|
|
Experimental: Gamification (Loss framing)
This group will receive a gamification intervention with loss framing.
|
Participants will take part in a 6-week game-based program designed to help them reach their daily step goals.
They are encouraged to maintain their daily step counts to achieve their daily step target over the 6-week intervention period.
The gamification design incorporates two theoretically effective behavioral economics principles, "Fresh Start" and "Loss Aversion".
All participants start from the Silver rank (middle rank), and their rank changes based on each final point of the week.
The ranks are set from top to bottom as Platinum, Gold, Silver, Bronze, and Blue.
In loss framing, if the daily step target is 6000 steps, maintaining 70 points for achieving 6000 steps on day 1, and a deduction of 10 points for not achieving it.
In gain framing, achieving 6000 steps on day 1 results in an addition of 10 points, with no increase for not achieving it.
After one week, ranks increase if the points at midnight on Sunday are 40 or above, and decrease if below this threshold.
|
|
Experimental: Gamification (Gain framing)
This group will receive a gamification intervention with gain framing.
|
Participants will take part in a 6-week game-based program designed to help them reach their daily step goals.
They are encouraged to maintain their daily step counts to achieve their daily step target over the 6-week intervention period.
The gamification design incorporates two theoretically effective behavioral economics principles, "Fresh Start" and "Loss Aversion".
All participants start from the Silver rank (middle rank), and their rank changes based on each final point of the week.
The ranks are set from top to bottom as Platinum, Gold, Silver, Bronze, and Blue.
In loss framing, if the daily step target is 6000 steps, maintaining 70 points for achieving 6000 steps on day 1, and a deduction of 10 points for not achieving it.
In gain framing, achieving 6000 steps on day 1 results in an addition of 10 points, with no increase for not achieving it.
After one week, ranks increase if the points at midnight on Sunday are 40 or above, and decrease if below this threshold.
|
|
Experimental: Gamification (Loss framing) + Social support
This group will receive a gamification intervention with loss framing and a social support intervention.
|
Participants will take part in a 6-week game-based program designed to help them reach their daily step goals.
They are encouraged to maintain their daily step counts to achieve their daily step target over the 6-week intervention period.
The gamification design incorporates two theoretically effective behavioral economics principles, "Fresh Start" and "Loss Aversion".
All participants start from the Silver rank (middle rank), and their rank changes based on each final point of the week.
The ranks are set from top to bottom as Platinum, Gold, Silver, Bronze, and Blue.
In loss framing, if the daily step target is 6000 steps, maintaining 70 points for achieving 6000 steps on day 1, and a deduction of 10 points for not achieving it.
In gain framing, achieving 6000 steps on day 1 results in an addition of 10 points, with no increase for not achieving it.
After one week, ranks increase if the points at midnight on Sunday are 40 or above, and decrease if below this threshold.
Participants in this group are asked to designate a family member or friend to provide social support.
This supporter is encouraged to check the participant's progress and provide support during the interventional period.
The supporter will also receive weekly emails throughout the period, informing them about the participant's daily step counts, achievement status, points, levels, and other relevant information.
|
|
Experimental: Gamification (Gain framing) + Social support
This group will receive a gamification intervention with gain framing and a social support intervention.
|
Participants will take part in a 6-week game-based program designed to help them reach their daily step goals.
They are encouraged to maintain their daily step counts to achieve their daily step target over the 6-week intervention period.
The gamification design incorporates two theoretically effective behavioral economics principles, "Fresh Start" and "Loss Aversion".
All participants start from the Silver rank (middle rank), and their rank changes based on each final point of the week.
The ranks are set from top to bottom as Platinum, Gold, Silver, Bronze, and Blue.
In loss framing, if the daily step target is 6000 steps, maintaining 70 points for achieving 6000 steps on day 1, and a deduction of 10 points for not achieving it.
In gain framing, achieving 6000 steps on day 1 results in an addition of 10 points, with no increase for not achieving it.
After one week, ranks increase if the points at midnight on Sunday are 40 or above, and decrease if below this threshold.
Participants in this group are asked to designate a family member or friend to provide social support.
This supporter is encouraged to check the participant's progress and provide support during the interventional period.
The supporter will also receive weekly emails throughout the period, informing them about the participant's daily step counts, achievement status, points, levels, and other relevant information.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in mean daily step counts
Time Frame: From enrollment to the end of intervention period at 8 weeks (2-weeks run-in and 6-weeks intervention period)
|
The primary outcome is change in mean daily step counts from baseline to the 6-week intervention period.
|
From enrollment to the end of intervention period at 8 weeks (2-weeks run-in and 6-weeks intervention period)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percentage of days achieving their step goals
Time Frame: From enrollment to the end of follow-up period at 14 weeks
|
Secondary outcomes include the percentage of days achieving their step goals during the intervention and follow-up periods and the change in daily step counts from baseline to follow-up period.
|
From enrollment to the end of follow-up period at 14 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in International Physical Activity Questionnaire (IPAQ)
Time Frame: From enrollment to the end of follow-up period at 14 weeks
|
Change in the participant's subjective assessment of physical activity level measured using the International Physical Activity Questionnaire (IPAQ) Short Form.
This is a survey that investigates how individuals engage in physical activity (how they move their bodies) in their daily lives.
It is a questionnaire that assesses the duration and frequency of exercise based on intensity levels.
|
From enrollment to the end of follow-up period at 14 weeks
|
|
Change in Body weight (BMI)
Time Frame: From enrollment to the end of follow-up period at 14 weeks
|
Change in body weight (BMI) (kg/m^2)
|
From enrollment to the end of follow-up period at 14 weeks
|
|
Change in LDL/HDL cholesterol
Time Frame: From enrollment to the end of follow-up period at 14 weeks
|
Change in LDL/HDL cholesterol (mg/dL)
|
From enrollment to the end of follow-up period at 14 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Atsushi Mizuno, MD, PhD, Department of Cardiovascular Medicine, St. Luke's International Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 12, 2024
Primary Completion (Estimated)
March 31, 2026
Study Completion (Estimated)
March 31, 2026
Study Registration Dates
First Submitted
May 30, 2024
First Submitted That Met QC Criteria
June 4, 2024
First Posted (Actual)
June 6, 2024
Study Record Updates
Last Update Posted (Actual)
May 15, 2025
Last Update Submitted That Met QC Criteria
May 12, 2025
Last Verified
May 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 23-RCK043
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Diseases
-
Hull University Teaching Hospitals NHS TrustNot yet recruitingCardiovascular Surgery | Cardiovascular Diseases (CVD)United Kingdom
-
Weill Medical College of Cornell UniversityAmerican Heart AssociationRecruitingCardiovascular | Cardiovascular Health | Cardiovascular (CV) Risk | Cardiovascular Disease (CVD) Risk FactorsUnited States
-
Fu Jen Catholic UniversityRecruitingCardiovascular Disease | Cardiovascular SurgeryTaiwan
-
Medical College of WisconsinNational Center for Complementary and Integrative Health (NCCIH)CompletedCardiovascular Diseases | Cardiovascular Risk Factor | Cardiovascular HealthUnited States
-
Hospital Mutua de TerrassaCompleted
-
IRCCS Policlinico S. DonatoIRCCS San Raffaele; Fondazione Policlinico Universitario Agostino Gemelli IRCCS and other collaboratorsRecruitingCardiovascular Risk | Genetic Cardiovascular RiskItaly
-
Oregon Health and Science UniversityCompletedCardiovascular Disease | Cardiovascular Risk FactorsUnited States
-
Women's College HospitalUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; Brigham... and other collaboratorsUnknownCARDIOVASCULAR DISEASESCanada, United States
-
Groupe Hospitalier Paris Saint JosephTerminatedCARDIOVASCULAR DISEASESFrance
-
Children's Hospital Medical Center, CincinnatiRecruitingCardiovascular Diseases (CVD)United States
Clinical Trials on Gamification (Gain/Loss framing)
-
University of North Carolina, Chapel HillGilead SciencesCompletedHIV PreventionUnited States
-
Qazvin University Of Medical SciencesCompletedHealth BehaviorIran, Islamic Republic of
-
National University Hospital, SingaporeNot yet recruitingSkin Cancer | Skin Cancer Prevention | Benign Skin Growth
-
University of GlasgowUniversity of Pisa; Göteborg UniversityCompletedObesity | Cardiovascular Disease | Diabetes | Weight Loss | Weight GainUnited Kingdom
-
University of PennsylvaniaNational Institute on Aging (NIA)WithdrawnCardiovascular DiseasesUnited States
-
University of PennsylvaniaActive, not recruiting
-
Bispebjerg HospitalNot yet recruitingObesity | Weight Loss | Weight Gain | Arthropathy of Knee | Arthropathy of Hip | Arthritis Knee | Persistent Postsurgical Pain
-
Guangzhou Blood CenterCompleted
-
The Third Affiliated Hospital of Soochow UniversityNot yet recruitingDiabetes Mellitus | Diabetic Foot Ulcer (DFU) | Risk Perception | Peripheral Neuropathy With Type 2 Diabetes
-
Harvard Pilgrim Health CareSeattle Children's HospitalCompleted